Promega Corporation

ALK6 Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human ALK6 (BMPR1B) (149–end) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. ALK6 (also known as BMPR1B) is a member of the transmembrane serine/threonine kinase that is the member of the bone morphogenetic protein (BMP) receptor, which is closely related to the activin receptors, ACVR1 and ACVR2. ALK6 is mainly involved in the endochondral bone formation and embryogenesis. ALK6 is expressed in normal and cancerous prostate tissues and used in the endocrine therapy given to prostate cancer patients (1). ALK6 receptor trafficking also ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega Italia only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart
ALK6 Kinase Enzyme System
Close Window

ALK6 Kinase Enzyme System  Components

10μg
- V4052 € 431,00 Add to cart

ALK6 Kinase Enzyme System

Close Window

ALK6 Kinase Enzyme System

 Components

1mg
- V6273 Please Enquire
ADP-Glo™ Kinase Assay + ALK6 Kinase Enzyme System
Close Window

ADP-Glo™ Kinase Assay + ALK6 Kinase Enzyme System  Components

  • ALK6 Kinase Enzyme System

    V40521 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V4053 Please Enquire


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V4052, V6273, V4053 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V4053 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V4053 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V4053 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V4053 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V4053 U.S. Pat. No. 8,183,007 and other patents pending.

V4053 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V4053 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Prefer a different language?

Your country is set to Italy. Your language is set to italiano. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.